Blood-substitute study is criticized by U.S. agency.
Thomas M
TM
Burton
D001802:Blood Substitutes / Q000009:adverse effects* / Q000627:therapeutic use; D001803:Blood Transfusion; D035061:Control Groups; D030881:Disclosure / Q000941:ethics; D004345:Drug Industry / Q000941:ethics; D006801:Humans; D019724:Presumed Consent / Q000941:ethics; D016032:Randomized Controlled Trials as Topic / Q000009:adverse effects* / Q000941:ethics*; D035842:Research Subjects; D014474:Unconsciousness; D014481:United States; D014486:United States Food and Drug Administration; D018172:United States Office of Research Integrity; D028761:Withholding Treatment; D014947:Wounds and Injuries / Q000628:therapy*
D001802:Blood Substitutes